OptimizeRx Profit Margin

The latest profit margin for OPRX is 6.37% as of March 2026. That compares with -16.33% in the prior-year period — up 139.0% year over year. That is below the Healthcare sector average of 15.58%. Investors often review this figure alongside OptimizeRx's historical trend and sector peers before judging valuation or financial health.

Over the past year, OPRX's profit margin moved from -16.33% to 6.37% — a 139.0% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in OptimizeRx's valuation or profitability profile.

Against Healthcare companies, OPRX currently prints 6.37% for profit margin, while the sector average sits near 15.58%. That is roughly 59.1% below the sector mean. Large gaps often invite a closer look at OptimizeRx's growth, margins, and balance sheet.

Profit Margin shows how effectively OptimizeRx converts resources into returns. At 6.37%, OPRX may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -16.33% in the prior-year period — up 139.0% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting OPRX's profit margin (6.37%), review year-over-year change from -16.33%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.